Menu

Qualigen Therapeutics, Inc. QLGN

Full chart Compare
Set alert

Price alert · QLGN

All alert types
3.21 0.00 (+0.00%)

At closeNov 18, 2025, 4:00 PM EST

2.86 Day range 3.34
3.34 52-week range 30.50
YTD
-23.75%
1 year
-11.81%

Revenue & Expenses

Other Operating Income → Expenses: $5.20MExpenses → Gross Loss: $4.50KExpenses → Selling, General & Admin: $6.09MExpenses → Research & Development: $5.21MExpenses → Other Expenses: $7.32MIncome Tax Benefit → Expenses: $4.79KNet Loss → Expenses: $13.42MRevenue → Cost of Revenue: $5.20MOther Operating Income$5.20MIncome Tax Benefit$4.79KNet Loss$13.42MCost of Revenue$5.21MExpenses$18.63MGross Loss$4.50KSelling, General & Admin$6.09MResearch & Development$5.21MOther Expenses$7.32MRevenue$5.20M

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

QLGN annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Mar 31, 2020
5.76M11.30M14.76M23.98M3.08M
1.20M5.21M4.49M11.72M1.21M
4.20M6.10M10.27M12.27M1.88M
-5.76M-11.30M-14.76M-22.66M-1.50M
908.94K1.52M34.40K-42.69K283.10K
6.33K-4.79K6.55K5.43K4.00K
-6.26M-13.42M-18.64M-17.90M-1.79M
-6.35M-13.42M-18.64M-17.90M-1.79M
-6.35M-13.42M-18.64M-17.90M-1.79M
-6.26M-13.76M-21.03M-17.90M-1.79M
100.00K1.29M7.14M00
-17.55-132.25-243.00-305.00-160.00
-17.55-132.25-243.00-305.00-160.00
-17.55-132.25-243.00-305.00-160.00
-5.34M-11.90M-18.60M-17.93M-1.50M
-5.34M-11.90M-18.60M-17.93M-1.50M
87.60K0000
361.59K101.45K76.81K58.67K11.20K
361.59K101.45K76.81K58.67K11.20K